Steven Cohen's BBIO Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.53 M shares of BridgeBio Pharma, Inc. (BBIO) worth $113.64 M, representing 0.13% of the portfolio. First purchased in 2019-Q2, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in BBIO, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 1.53 M shares. Largest reduction occurred in Q2 2025, reducing 198,780 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's BridgeBio Pharma (BBIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly BridgeBio Pharma (BBIO) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +1.53 M | New Buy | 1.53 M | $74.48 |
| Q2 2025 | -198,780 | Sold Out | 0 | $0.00 |
| Q1 2025 | +198,780 | New Buy | 198,780 | $34.57 |
| Q4 2023 | -5,265 | Sold Out | 0 | $0.00 |
| Q3 2023 | -61,409 | Reduce 92.10% | 5,265 | $26.37 |
| Q2 2023 | -32,500 | Reduce 32.77% | 66,674 | $17.20 |
| Q1 2023 | +99,174 | New Buy | 99,174 | $16.58 |
| Q1 2022 | -50,312 | Sold Out | 0 | $0.00 |
| Q4 2021 | +50,312 | New Buy | 50,312 | $16.68 |
| Q3 2019 | -13,200 | Sold Out | 0 | $0.00 |
| Q2 2019 | +13,200 | New Buy | 13,200 | $26.97 |
Steven Cohen's BridgeBio Pharma Investment FAQs
Steven Cohen first purchased BridgeBio Pharma, Inc. (BBIO) in Q2 2019, acquiring 13,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held BridgeBio Pharma, Inc. (BBIO) for 11 quarters since Q2 2019.
Steven Cohen's largest addition to BridgeBio Pharma, Inc. (BBIO) was in Q2 2026, adding 1,525,782 shares worth $113.64 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,525,782 shares of BridgeBio Pharma, Inc. (BBIO), valued at approximately $113.64 M.
As of the Q2 2026 filing, BridgeBio Pharma, Inc. (BBIO) represents approximately 0.13% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in BridgeBio Pharma, Inc. (BBIO) was 1,525,782 shares, as reported at the end of Q2 2026.